Business
Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc.
RAHWAY, N.J., April 24, 2026--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), in connection with Merck’s pending acquisition of Terns Pharmaceuticals, Inc. ("Terns") (Nasdaq: TERN) expired at 11:59 p.m., Eastern Time, on April 23, 2026.
About this update from Terns Pharmaceuticals, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":217,"url":"https://media.zenfs.com/en/business-wire.com/53af817d3f5019769e03e30197927992"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/tqzixwGE2aMPOoQjGjF_6w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQzNA--/https://media.zenfs.com/en/business-wire.com/53af817d3f5019769e03e30197927992","width":480,"height":217}},"lazy":false},{"type":"text","content":"RAHWAY, N.J., April 24, 2026--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), in connection with Merck’s pending acquisition of Terns Pharmaceuticals, Inc. ("Terns") (Nasdaq: TERN) expired at 11:59 p.m., Eastern Time, on April 23, 2026.","length":422,"tagName":"p"},{"type":"text","content":"As previously announced on April 7, 2026, Merck commenced, through a subsidiary, a cash tender offer to purchase all outstanding shares of common stock of Terns, for $53.00 net in cash for each share of Terns common stock validly tendered and not validly withdrawn in the offer, without interest and less any applicable tax withholding. The expiration of the HSR waiting period satisfies one of the conditions necessary for the consummation of the tender offer. Consummation of the tender offer remains subject to other conditions described in the tender offer statement on Schedule TO filed with the U.S. Securities and Exchange Commission (the "SEC") on April 7, 2026, including the tender of shares representing more than 50% of the total number of Terns’ outstanding shares.","length":788,"tagName":"p"},{"type":"text","content":"About Merck","length":11,"tagName":"p"},{"type":"text","content":"At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that ad...